Stem cell research history is a very long part of the stem cell research, here we will discuss only for the hematopoietic stem cell research history part, if not only the hematopoietic part, I’m very sure that all of the people who’s read this article will be very sleepy because it will be very long, and for me…it’s just for us to know the history in the past, but we must keep moving forward for still be meaningfull for a lot of part in this world especially in people’s health, to bring healthiness for all of the people, to make a better health for everyone in this world, without exception.
Hematopoietic stem cells (HSCs) have been heavily researched for decades, as it’s promising cures for Blood related diseases (such as Leukemia and lymphoma) However, their discovery was not made in search for such a cure, but stumbled upon while dealing with another serious medical issue of the time: radiation. While trying to treat people exposed to lethal doses of radiation during World War II, transplants from the spleen and bone marrow were found to rescue these victims (Ford et al., 1956).
It was not until later that scientists determined that the HSCs present in these tissues were what was restoring the damaged tissues, observed by performing transplants using lethally irradiated mouse and rat models (Becker et al., 1963). HSCs in humans were further characterized and cultured in the 1980s (Morstyn et al., 1980; Sutherland et al., 1989; Sutherland et al., 1990).
The important thing is how HSCs can be used in many other medical applications as well, not only better understood how HSCs from a donor animal can save a lethally irradiated recipient animal. HSCs are able to give rise to all cells in the hematopoietic system, which includes myeloid elements (i.e. red blood cells, white blood cells, platelets) and the lymphatic system (i.e. T-Cells) (Regenerative Medicine, 2006). HSCs can be collected from adult bone marrow, some fetal tissues (liver, spleen, thymus), umbilical chords, and peripheral blood, in recent years there has been a great shift towards obtaining HSCs mainly from peripheral blood, using a much simpler and less controversial procedure, though achieving a large enough number of HSCs for transplants is still an obstacle to overcome (Stem Cells, 2001). HSCs are now being used to treat cancers of the hematopoietic system (leukemia and lymphomas), replenish cells lost to high-doses of chemotherapy, and fight against autoimmune diseases, in addition to other medical applications (Regenerative Medicine, 2006).
Multiple studies have shown that HSCs transplanted into a donor animal can travel to such areas especially when they are injured.the unique characteristic of HSCs is their mobility; HSCs can travel out of the bone marrow and into surrounding tissues, such as peripheral blood, nearby bones, the spleen, and many other tissues. It is thought that an injury causes a loss of cells normally functioning in the hematopoietic system and this loss must quickly be replaced by HSCs, which migrate to where they are needed and then differentiate into the required, lost derivatives (Whetton and Graham, 1999; Regenerative Medicine, 2006; Chamberlain et al., 2007). While HSCs have been clinically studied to a large extent relative to other human stem cells, much work remains to be done to fully understand their molecular interactions.